Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

2.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.8K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

1.6K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

6.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.2K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

4.7K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K
Selectins01:25

Selectins

3.6K
Cell adhesion is  an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A microfluidic platform for isolating functional mitochondria and restoring bioenergetic activity in hypoxia-injured cardiomyocytes.

International journal of biological macromolecules·2026
Same author

Essential but neglected: securing the global supply of human hyperimmune immunoglobulins.

The Lancet. Haematology·2026
Same author

Platelet membrane-coated nanoparticles: Bioengineering principles, quality control, and translational opportunities.

APL bioengineering·2026
Same author

Real-world outcomes of patients with multiple myeloma who reach third-line therapy: a Canadian report.

Blood neoplasia·2026
Same author

Immune dysregulation in mania: A proof-of-concept platelet proteomics study.

Psychiatry and clinical neurosciences·2026
Same author

Platelet-derived and platelet secretome biotherapies for precision neuromedicine.

Trends in molecular medicine·2026

Related Experiment Video

Updated: May 2, 2026

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice
11:18

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Published on: April 2, 2013

15.0K

Platelet-cancer interactions.

Hadi A Goubran1, Julie Stakiw1, Mirjana Radosevic2

  • 1Saskatoon Cancer Centre and Division of Oncology, Department of Medicine, College of Medicine, University of Saskatchewan, Saskatoon, Canada.

Seminars in Thrombosis and Hemostasis
|March 5, 2014
PubMed
Summary

Platelets significantly impact cancer progression and thrombosis by activating tumor cells and releasing growth factors. Inhibiting platelet activation may reduce cancer and thrombosis risks.

More Related Videos

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

21.9K
Intravital Microscopy of Leukocyte-endothelial and Platelet-leukocyte Interactions in Mesenterial Veins in Mice
05:12

Intravital Microscopy of Leukocyte-endothelial and Platelet-leukocyte Interactions in Mesenterial Veins in Mice

Published on: August 13, 2015

11.8K

Related Experiment Videos

Last Updated: May 2, 2026

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice
11:18

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Published on: April 2, 2013

15.0K
Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

21.9K
Intravital Microscopy of Leukocyte-endothelial and Platelet-leukocyte Interactions in Mesenterial Veins in Mice
05:12

Intravital Microscopy of Leukocyte-endothelial and Platelet-leukocyte Interactions in Mesenterial Veins in Mice

Published on: August 13, 2015

11.8K

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Platelets are critical for hemostasis and thrombosis.
  • Emerging evidence highlights broader roles in health and disease.
  • Tumor cells influence platelets numerically and functionally, initiating cancer-induced thrombosis.

Purpose of the Study:

  • To elucidate the complex interplay between platelets and cancer.
  • To understand how platelets contribute to tumor growth, metastasis, and immune evasion.
  • To explore therapeutic strategies targeting platelet activation in cancer.

Main Methods:

  • Review of existing literature on platelet-cancer interactions.
  • Analysis of signaling pathways involved in tumor cell-induced platelet activation.
  • Examination of platelet-derived factors influencing tumor progression.

Main Results:

  • Tumor cells activate platelets via direct signaling and cytokines.
  • Activated platelets release growth factors promoting tumor growth, tethering, and spread.
  • Platelets contribute to immune evasion through molecular mimicry.
  • A positive feedback loop exists between platelets and tumor microvesicles.

Conclusions:

  • Platelets are key mediators in cancer development and progression.
  • Targeting platelet activation pathways offers a potential therapeutic strategy.
  • Inhibiting platelet activation may reduce both cancer and thrombosis risks.